GSK plc GLAXF OTC

GSK plc (GLAXF) generated $2.09B in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $572.91M, free cash flow was $1.52B.

Free cash flow margin was 17.6% of revenue. Cash conversion ratio was 3.29x, indicating earnings are backed by cash.

The company returned $645.9M in dividends to shareholders during the quarter.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (90/100, Pass) — $1.52B (17.6% margin) supports a durable competitive advantage
• INCOME (70/100) — Cash conversion ratio was 3.29x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 70/100 with 4/7 criteria passed.